Topic: Serevent
FDA urges safety curbs to decrease use of 4 popular asthma drugs, citing lifethreatening riskThe government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk ...
LONDON (Reuters) - Common asthma reliever drugs taken by millions of children around the world may increase the risk of asthma attacks in some patients with a particular genetic make-up, British scientists said on Tuesday. The researchers found that salbutamol, a popular ...
FDA advisers: Advair OK, but some long-acting asthma medications too risky for useGovernment health advisers recommended restrictions Thursday on some long-acting asthma drugs, although not Advair, a top-selling medication. Outside experts advising the Food and Drug Administration said Foradil and Serevent no ...
Ban on long-acting medications could set back patients, asthma doctors sayIn recent years, millions of asthma patients have started using long-acting drugs to help them breathe more normally, allowing for nights of uninterrupted sleep or workouts at the gym. Now the Food ...
The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday. But a less widely used medication, Serevent, had a significantly higher rate of complications when ...
